nodes	percent_of_prediction	percent_of_DWPC	metapath
Fluocinonide—NR3C1—Fluoxymesterone—breast cancer	0.222	1	CbGbCtD
Fluocinonide—Fluprednidene Acetate—Exemestane—breast cancer	0.0626	0.121	CrCrCtD
Fluocinonide—Methylprednisolone—Exemestane—breast cancer	0.0585	0.113	CrCrCtD
Fluocinonide—Amcinonide—Fluoxymesterone—breast cancer	0.048	0.0925	CrCrCtD
Fluocinonide—Clobetasol propionate—Fluoxymesterone—breast cancer	0.0467	0.0901	CrCrCtD
Fluocinonide—Desoximetasone—Fluoxymesterone—breast cancer	0.0444	0.0857	CrCrCtD
Fluocinonide—Triamcinolone—Fluoxymesterone—breast cancer	0.0434	0.0837	CrCrCtD
Fluocinonide—Fluorometholone—Fluoxymesterone—breast cancer	0.0434	0.0837	CrCrCtD
Fluocinonide—Fluprednidene Acetate—Fluoxymesterone—breast cancer	0.0434	0.0837	CrCrCtD
Fluocinonide—Mometasone—Fluoxymesterone—breast cancer	0.0434	0.0837	CrCrCtD
Fluocinonide—Dexamethasone—Fluoxymesterone—breast cancer	0.0424	0.0818	CrCrCtD
Fluocinonide—Betamethasone—Fluoxymesterone—breast cancer	0.0424	0.0818	CrCrCtD
Fluocinonide—SMO—mammary gland—breast cancer	0.00575	0.106	CbGeAlD
Fluocinonide—SMO—nipple—breast cancer	0.00476	0.088	CbGeAlD
Fluocinonide—SMO—embryo—breast cancer	0.00393	0.0726	CbGeAlD
Fluocinonide—SMO—skin of body—breast cancer	0.00305	0.0564	CbGeAlD
Fluocinonide—SMO—endometrium—breast cancer	0.00287	0.0532	CbGeAlD
Fluocinonide—SMO—uterus—breast cancer	0.00265	0.049	CbGeAlD
Fluocinonide—SMO—pituitary gland—breast cancer	0.0026	0.0481	CbGeAlD
Fluocinonide—SMO—adipose tissue—breast cancer	0.00259	0.0479	CbGeAlD
Fluocinonide—SMO—female reproductive system—breast cancer	0.00238	0.044	CbGeAlD
Fluocinonide—SMO—adrenal gland—breast cancer	0.00232	0.043	CbGeAlD
Fluocinonide—SMO—female gonad—breast cancer	0.00217	0.0401	CbGeAlD
Fluocinonide—SMO—endocrine gland—breast cancer	0.00201	0.0373	CbGeAlD
Fluocinonide—SERPINA6—pituitary gland—breast cancer	0.00143	0.0265	CbGeAlD
Fluocinonide—SMO—lymph node—breast cancer	0.00139	0.0258	CbGeAlD
Fluocinonide—SERPINA6—female reproductive system—breast cancer	0.00131	0.0243	CbGeAlD
Fluocinonide—SERPINA6—adrenal gland—breast cancer	0.00128	0.0237	CbGeAlD
Fluocinonide—SERPINA6—bone marrow—breast cancer	0.00124	0.0229	CbGeAlD
Fluocinonide—NR3C1—nipple—breast cancer	0.00115	0.0212	CbGeAlD
Fluocinonide—SERPINA6—endocrine gland—breast cancer	0.00111	0.0205	CbGeAlD
Fluocinonide—NR3C1—embryo—breast cancer	0.000947	0.0175	CbGeAlD
Fluocinonide—NR3C1—epithelium—breast cancer	0.000773	0.0143	CbGeAlD
Fluocinonide—NR3C1—skin of body—breast cancer	0.000735	0.0136	CbGeAlD
Fluocinonide—NR3C1—endometrium—breast cancer	0.000693	0.0128	CbGeAlD
Fluocinonide—NR3C1—uterus—breast cancer	0.000639	0.0118	CbGeAlD
Fluocinonide—NR3C1—pituitary gland—breast cancer	0.000627	0.0116	CbGeAlD
Fluocinonide—NR3C1—adipose tissue—breast cancer	0.000625	0.0116	CbGeAlD
Fluocinonide—NR3C1—female reproductive system—breast cancer	0.000574	0.0106	CbGeAlD
Fluocinonide—NR3C1—adrenal gland—breast cancer	0.00056	0.0104	CbGeAlD
Fluocinonide—NR3C1—bone marrow—breast cancer	0.000542	0.01	CbGeAlD
Fluocinonide—NR3C1—female gonad—breast cancer	0.000522	0.00967	CbGeAlD
Fluocinonide—NR3C1—endocrine gland—breast cancer	0.000486	0.00899	CbGeAlD
Fluocinonide—Fluocinolone Acetonide—PLA2G4A—breast cancer	0.000437	0.121	CrCbGaD
Fluocinonide—NR3C1—lymph node—breast cancer	0.000336	0.00621	CbGeAlD
Fluocinonide—Dry skin—Fluorouracil—breast cancer	0.000311	0.00296	CcSEcCtD
Fluocinonide—Dizziness—Fulvestrant—breast cancer	0.000309	0.00294	CcSEcCtD
Fluocinonide—Pain—Anastrozole—breast cancer	0.000309	0.00293	CcSEcCtD
Fluocinonide—Pain—Letrozole—breast cancer	0.000309	0.00293	CcSEcCtD
Fluocinonide—Immune system disorder—Melphalan—breast cancer	0.000308	0.00292	CcSEcCtD
Fluocinonide—Dizziness—Toremifene—breast cancer	0.000305	0.0029	CcSEcCtD
Fluocinonide—Nasopharyngitis—Fluorouracil—breast cancer	0.000304	0.00288	CcSEcCtD
Fluocinonide—Erythema—Tamoxifen—breast cancer	0.000303	0.00288	CcSEcCtD
Fluocinonide—Immune system disorder—Goserelin—breast cancer	0.0003	0.00285	CcSEcCtD
Fluocinonide—Hypersensitivity—Exemestane—breast cancer	0.000299	0.00284	CcSEcCtD
Fluocinonide—Fluticasone Propionate—PLA2G4A—breast cancer	0.000299	0.0829	CrCbGaD
Fluocinonide—Rash—Fulvestrant—breast cancer	0.000295	0.0028	CcSEcCtD
Fluocinonide—Dermatitis—Fulvestrant—breast cancer	0.000295	0.0028	CcSEcCtD
Fluocinonide—Headache—Fulvestrant—breast cancer	0.000293	0.00278	CcSEcCtD
Fluocinonide—Pain—Raloxifene—breast cancer	0.000293	0.00278	CcSEcCtD
Fluocinonide—Rash—Toremifene—breast cancer	0.000291	0.00276	CcSEcCtD
Fluocinonide—Dermatitis—Toremifene—breast cancer	0.000291	0.00276	CcSEcCtD
Fluocinonide—Headache—Toremifene—breast cancer	0.000289	0.00275	CcSEcCtD
Fluocinonide—Erythema—Goserelin—breast cancer	0.000289	0.00275	CcSEcCtD
Fluocinonide—Pruritus—Exemestane—breast cancer	0.000288	0.00273	CcSEcCtD
Fluocinonide—Hypersensitivity—Ixabepilone—breast cancer	0.000283	0.00268	CcSEcCtD
Fluocinonide—Glycosuria—Epirubicin—breast cancer	0.000281	0.00267	CcSEcCtD
Fluocinonide—Swelling—Docetaxel—breast cancer	0.000278	0.00264	CcSEcCtD
Fluocinonide—Hyperglycaemia—Mitoxantrone—breast cancer	0.000277	0.00263	CcSEcCtD
Fluocinonide—Infection—Chlorambucil—breast cancer	0.000276	0.00262	CcSEcCtD
Fluocinonide—Pruritus—Ixabepilone—breast cancer	0.000271	0.00258	CcSEcCtD
Fluocinonide—Hyperglycaemia—Gemcitabine—breast cancer	0.000269	0.00256	CcSEcCtD
Fluocinonide—Swelling—Capecitabine—breast cancer	0.000269	0.00256	CcSEcCtD
Fluocinonide—Immune system disorder—Vinorelbine—breast cancer	0.000269	0.00255	CcSEcCtD
Fluocinonide—Dizziness—Exemestane—breast cancer	0.000269	0.00255	CcSEcCtD
Fluocinonide—Hypersensitivity—Anastrozole—breast cancer	0.000266	0.00253	CcSEcCtD
Fluocinonide—Dry skin—Paclitaxel—breast cancer	0.000265	0.00252	CcSEcCtD
Fluocinonide—Glycosuria—Doxorubicin—breast cancer	0.00026	0.00247	CcSEcCtD
Fluocinonide—Erythema—Vinorelbine—breast cancer	0.000259	0.00246	CcSEcCtD
Fluocinonide—Nasopharyngitis—Paclitaxel—breast cancer	0.000259	0.00246	CcSEcCtD
Fluocinonide—Immune system disorder—Thiotepa—breast cancer	0.000257	0.00244	CcSEcCtD
Fluocinonide—Rash—Exemestane—breast cancer	0.000256	0.00243	CcSEcCtD
Fluocinonide—Dermatitis—Exemestane—breast cancer	0.000256	0.00243	CcSEcCtD
Fluocinonide—Pruritus—Letrozole—breast cancer	0.000256	0.00243	CcSEcCtD
Fluocinonide—Pruritus—Anastrozole—breast cancer	0.000256	0.00243	CcSEcCtD
Fluocinonide—Headache—Exemestane—breast cancer	0.000255	0.00242	CcSEcCtD
Fluocinonide—Dizziness—Ixabepilone—breast cancer	0.000254	0.00241	CcSEcCtD
Fluocinonide—Hypersensitivity—Idarubicin—breast cancer	0.000253	0.0024	CcSEcCtD
Fluocinonide—Unspecified disorder of skin and subcutaneous tissue—Melphalan—breast cancer	0.000251	0.00238	CcSEcCtD
Fluocinonide—Erythema—Thiotepa—breast cancer	0.000247	0.00235	CcSEcCtD
Fluocinonide—Infection—Tamoxifen—breast cancer	0.000246	0.00233	CcSEcCtD
Fluocinonide—Unspecified disorder of skin and subcutaneous tissue—Goserelin—breast cancer	0.000245	0.00232	CcSEcCtD
Fluocinonide—Rash—Ixabepilone—breast cancer	0.000242	0.0023	CcSEcCtD
Fluocinonide—Dermatitis—Ixabepilone—breast cancer	0.000242	0.00229	CcSEcCtD
Fluocinonide—Infection—Melphalan—breast cancer	0.00024	0.00228	CcSEcCtD
Fluocinonide—Headache—Ixabepilone—breast cancer	0.00024	0.00228	CcSEcCtD
Fluocinonide—Dizziness—Letrozole—breast cancer	0.000239	0.00227	CcSEcCtD
Fluocinonide—Dizziness—Anastrozole—breast cancer	0.000239	0.00227	CcSEcCtD
Fluocinonide—Pain—Chlorambucil—breast cancer	0.000237	0.00225	CcSEcCtD
Fluocinonide—Skin disorder—Melphalan—breast cancer	0.000235	0.00223	CcSEcCtD
Fluocinonide—Infection—Goserelin—breast cancer	0.000235	0.00223	CcSEcCtD
Fluocinonide—Skin exfoliation—Methotrexate—breast cancer	0.000232	0.00221	CcSEcCtD
Fluocinonide—Nervous system disorder—Goserelin—breast cancer	0.000231	0.0022	CcSEcCtD
Fluocinonide—Skin disorder—Goserelin—breast cancer	0.000229	0.00218	CcSEcCtD
Fluocinonide—Rash—Letrozole—breast cancer	0.000228	0.00216	CcSEcCtD
Fluocinonide—Rash—Anastrozole—breast cancer	0.000228	0.00216	CcSEcCtD
Fluocinonide—Dermatitis—Anastrozole—breast cancer	0.000227	0.00216	CcSEcCtD
Fluocinonide—Dermatitis—Letrozole—breast cancer	0.000227	0.00216	CcSEcCtD
Fluocinonide—Dizziness—Raloxifene—breast cancer	0.000227	0.00215	CcSEcCtD
Fluocinonide—Headache—Letrozole—breast cancer	0.000226	0.00215	CcSEcCtD
Fluocinonide—Headache—Anastrozole—breast cancer	0.000226	0.00215	CcSEcCtD
Fluocinonide—Hyperglycaemia—Paclitaxel—breast cancer	0.000226	0.00214	CcSEcCtD
Fluocinonide—Dermatitis contact—Epirubicin—breast cancer	0.000225	0.00214	CcSEcCtD
Fluocinonide—Dry skin—Docetaxel—breast cancer	0.000225	0.00213	CcSEcCtD
Fluocinonide—Immune system disorder—Irinotecan—breast cancer	0.000222	0.0021	CcSEcCtD
Fluocinonide—Nasopharyngitis—Docetaxel—breast cancer	0.000219	0.00208	CcSEcCtD
Fluocinonide—Unspecified disorder of skin and subcutaneous tissue—Vinorelbine—breast cancer	0.000219	0.00208	CcSEcCtD
Fluocinonide—Dry skin—Capecitabine—breast cancer	0.000218	0.00207	CcSEcCtD
Fluocinonide—Pain—Vinblastine—breast cancer	0.000218	0.00207	CcSEcCtD
Fluocinonide—Skin exfoliation—Epirubicin—breast cancer	0.000218	0.00207	CcSEcCtD
Fluocinonide—Rash—Idarubicin—breast cancer	0.000216	0.00205	CcSEcCtD
Fluocinonide—Rash—Raloxifene—breast cancer	0.000216	0.00205	CcSEcCtD
Fluocinonide—Immune system disorder—Gemcitabine—breast cancer	0.000216	0.00205	CcSEcCtD
Fluocinonide—Dermatitis—Idarubicin—breast cancer	0.000216	0.00205	CcSEcCtD
Fluocinonide—Dermatitis—Raloxifene—breast cancer	0.000216	0.00205	CcSEcCtD
Fluocinonide—Headache—Raloxifene—breast cancer	0.000215	0.00204	CcSEcCtD
Fluocinonide—Headache—Idarubicin—breast cancer	0.000215	0.00204	CcSEcCtD
Fluocinonide—Erythema—Mitoxantrone—breast cancer	0.000214	0.00203	CcSEcCtD
Fluocinonide—Nasopharyngitis—Capecitabine—breast cancer	0.000212	0.00202	CcSEcCtD
Fluocinonide—Pain—Tamoxifen—breast cancer	0.000211	0.00201	CcSEcCtD
Fluocinonide—Infection—Vinorelbine—breast cancer	0.00021	0.00199	CcSEcCtD
Fluocinonide—Unspecified disorder of skin and subcutaneous tissue—Thiotepa—breast cancer	0.000209	0.00199	CcSEcCtD
Fluocinonide—Dermatitis contact—Doxorubicin—breast cancer	0.000208	0.00198	CcSEcCtD
Fluocinonide—Erythema—Gemcitabine—breast cancer	0.000208	0.00198	CcSEcCtD
Fluocinonide—Nervous system disorder—Vinorelbine—breast cancer	0.000207	0.00197	CcSEcCtD
Fluocinonide—Pain—Melphalan—breast cancer	0.000207	0.00196	CcSEcCtD
Fluocinonide—Skin disorder—Vinorelbine—breast cancer	0.000205	0.00195	CcSEcCtD
Fluocinonide—Erythema—Fluorouracil—breast cancer	0.000205	0.00194	CcSEcCtD
Fluocinonide—Hypersensitivity—Chlorambucil—breast cancer	0.000205	0.00194	CcSEcCtD
Fluocinonide—Pain—Goserelin—breast cancer	0.000202	0.00192	CcSEcCtD
Fluocinonide—Skin exfoliation—Doxorubicin—breast cancer	0.000201	0.00191	CcSEcCtD
Fluocinonide—Infection—Thiotepa—breast cancer	0.000201	0.0019	CcSEcCtD
Fluocinonide—Nervous system disorder—Thiotepa—breast cancer	0.000198	0.00188	CcSEcCtD
Fluocinonide—Fluticasone Propionate—PGR—breast cancer	0.000198	0.0548	CrCbGaD
Fluocinonide—Pruritus—Chlorambucil—breast cancer	0.000196	0.00186	CcSEcCtD
Fluocinonide—Skin disorder—Thiotepa—breast cancer	0.000196	0.00186	CcSEcCtD
Fluocinonide—Hypersensitivity—Vinblastine—breast cancer	0.000187	0.00178	CcSEcCtD
Fluocinonide—Hyperglycaemia—Capecitabine—breast cancer	0.000185	0.00176	CcSEcCtD
Fluocinonide—Hypersensitivity—Tamoxifen—breast cancer	0.000182	0.00173	CcSEcCtD
Fluocinonide—Betamethasone—PGR—breast cancer	0.000181	0.0502	CrCbGaD
Fluocinonide—Pain—Vinorelbine—breast cancer	0.000181	0.00172	CcSEcCtD
Fluocinonide—Immune system disorder—Paclitaxel—breast cancer	0.000181	0.00172	CcSEcCtD
Fluocinonide—Hypersensitivity—Melphalan—breast cancer	0.000178	0.00169	CcSEcCtD
Fluocinonide—Unspecified disorder of skin and subcutaneous tissue—Gemcitabine—breast cancer	0.000176	0.00167	CcSEcCtD
Fluocinonide—Pruritus—Tamoxifen—breast cancer	0.000175	0.00166	CcSEcCtD
Fluocinonide—Erythema—Paclitaxel—breast cancer	0.000174	0.00165	CcSEcCtD
Fluocinonide—Hypersensitivity—Goserelin—breast cancer	0.000174	0.00165	CcSEcCtD
Fluocinonide—Infection—Mitoxantrone—breast cancer	0.000173	0.00164	CcSEcCtD
Fluocinonide—Infection—Irinotecan—breast cancer	0.000173	0.00164	CcSEcCtD
Fluocinonide—Pain—Thiotepa—breast cancer	0.000173	0.00164	CcSEcCtD
Fluocinonide—Pruritus—Melphalan—breast cancer	0.000171	0.00163	CcSEcCtD
Fluocinonide—Nervous system disorder—Irinotecan—breast cancer	0.000171	0.00162	CcSEcCtD
Fluocinonide—Skin disorder—Mitoxantrone—breast cancer	0.000169	0.00161	CcSEcCtD
Fluocinonide—Infection—Gemcitabine—breast cancer	0.000169	0.0016	CcSEcCtD
Fluocinonide—Dizziness—Vinblastine—breast cancer	0.000168	0.0016	CcSEcCtD
Fluocinonide—Pruritus—Goserelin—breast cancer	0.000167	0.00159	CcSEcCtD
Fluocinonide—Nervous system disorder—Gemcitabine—breast cancer	0.000167	0.00158	CcSEcCtD
Fluocinonide—Infection—Fluorouracil—breast cancer	0.000166	0.00158	CcSEcCtD
Fluocinonide—Skin disorder—Gemcitabine—breast cancer	0.000165	0.00157	CcSEcCtD
Fluocinonide—Nervous system disorder—Fluorouracil—breast cancer	0.000164	0.00155	CcSEcCtD
Fluocinonide—Dizziness—Tamoxifen—breast cancer	0.000163	0.00155	CcSEcCtD
Fluocinonide—Headache—Vinblastine—breast cancer	0.000159	0.00151	CcSEcCtD
Fluocinonide—Dizziness—Goserelin—breast cancer	0.000156	0.00148	CcSEcCtD
Fluocinonide—Rash—Tamoxifen—breast cancer	0.000156	0.00148	CcSEcCtD
Fluocinonide—Hypersensitivity—Vinorelbine—breast cancer	0.000156	0.00148	CcSEcCtD
Fluocinonide—Dermatitis—Tamoxifen—breast cancer	0.000156	0.00148	CcSEcCtD
Fluocinonide—Headache—Tamoxifen—breast cancer	0.000155	0.00147	CcSEcCtD
Fluocinonide—Immune system disorder—Docetaxel—breast cancer	0.000153	0.00145	CcSEcCtD
Fluocinonide—Rash—Melphalan—breast cancer	0.000153	0.00145	CcSEcCtD
Fluocinonide—Dermatitis—Melphalan—breast cancer	0.000152	0.00145	CcSEcCtD
Fluocinonide—Dry skin—Epirubicin—breast cancer	0.000152	0.00144	CcSEcCtD
Fluocinonide—Triamcinolone—BCHE—breast cancer	0.000151	0.042	CrCbGaD
Fluocinonide—Pruritus—Vinorelbine—breast cancer	0.00015	0.00142	CcSEcCtD
Fluocinonide—Pain—Mitoxantrone—breast cancer	0.000149	0.00142	CcSEcCtD
Fluocinonide—Pain—Irinotecan—breast cancer	0.000149	0.00142	CcSEcCtD
Fluocinonide—Rash—Goserelin—breast cancer	0.000149	0.00141	CcSEcCtD
Fluocinonide—Hypersensitivity—Thiotepa—breast cancer	0.000149	0.00141	CcSEcCtD
Fluocinonide—Dermatitis—Goserelin—breast cancer	0.000149	0.00141	CcSEcCtD
Fluocinonide—Immune system disorder—Capecitabine—breast cancer	0.000148	0.00141	CcSEcCtD
Fluocinonide—Nasopharyngitis—Epirubicin—breast cancer	0.000148	0.0014	CcSEcCtD
Fluocinonide—Headache—Goserelin—breast cancer	0.000148	0.0014	CcSEcCtD
Fluocinonide—Erythema—Docetaxel—breast cancer	0.000148	0.0014	CcSEcCtD
Fluocinonide—Unspecified disorder of skin and subcutaneous tissue—Paclitaxel—breast cancer	0.000147	0.0014	CcSEcCtD
Fluocinonide—Pain—Gemcitabine—breast cancer	0.000145	0.00138	CcSEcCtD
Fluocinonide—Erythema—Capecitabine—breast cancer	0.000143	0.00136	CcSEcCtD
Fluocinonide—Pruritus—Thiotepa—breast cancer	0.000143	0.00136	CcSEcCtD
Fluocinonide—Pain—Fluorouracil—breast cancer	0.000143	0.00136	CcSEcCtD
Fluocinonide—Clobetasol propionate—CYP1A1—breast cancer	0.000142	0.0394	CrCbGaD
Fluocinonide—Dexamethasone—CYP17A1—breast cancer	0.000142	0.0394	CrCbGaD
Fluocinonide—Infection—Paclitaxel—breast cancer	0.000141	0.00134	CcSEcCtD
Fluocinonide—Dry skin—Doxorubicin—breast cancer	0.00014	0.00133	CcSEcCtD
Fluocinonide—Dizziness—Vinorelbine—breast cancer	0.00014	0.00133	CcSEcCtD
Fluocinonide—Nervous system disorder—Paclitaxel—breast cancer	0.000139	0.00132	CcSEcCtD
Fluocinonide—Skin disorder—Paclitaxel—breast cancer	0.000138	0.00131	CcSEcCtD
Fluocinonide—Nasopharyngitis—Doxorubicin—breast cancer	0.000137	0.0013	CcSEcCtD
Fluocinonide—Dizziness—Thiotepa—breast cancer	0.000134	0.00127	CcSEcCtD
Fluocinonide—Rash—Vinorelbine—breast cancer	0.000133	0.00127	CcSEcCtD
Fluocinonide—Dermatitis—Vinorelbine—breast cancer	0.000133	0.00126	CcSEcCtD
Fluocinonide—Headache—Vinorelbine—breast cancer	0.000132	0.00126	CcSEcCtD
Fluocinonide—Hyperglycaemia—Epirubicin—breast cancer	0.000129	0.00122	CcSEcCtD
Fluocinonide—Hypersensitivity—Irinotecan—breast cancer	0.000128	0.00122	CcSEcCtD
Fluocinonide—Hypersensitivity—Mitoxantrone—breast cancer	0.000128	0.00122	CcSEcCtD
Fluocinonide—Rash—Thiotepa—breast cancer	0.000127	0.00121	CcSEcCtD
Fluocinonide—Dermatitis—Thiotepa—breast cancer	0.000127	0.00121	CcSEcCtD
Fluocinonide—Headache—Thiotepa—breast cancer	0.000126	0.0012	CcSEcCtD
Fluocinonide—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—breast cancer	0.000125	0.00119	CcSEcCtD
Fluocinonide—Betamethasone—CYP19A1—breast cancer	0.000124	0.0344	CrCbGaD
Fluocinonide—Hypersensitivity—Fluorouracil—breast cancer	0.000123	0.00117	CcSEcCtD
Fluocinonide—Pain—Paclitaxel—breast cancer	0.000122	0.00115	CcSEcCtD
Fluocinonide—Unspecified disorder of skin and subcutaneous tissue—Capecitabine—breast cancer	0.000121	0.00115	CcSEcCtD
Fluocinonide—Pruritus—Gemcitabine—breast cancer	0.00012	0.00114	CcSEcCtD
Fluocinonide—Infection—Docetaxel—breast cancer	0.00012	0.00114	CcSEcCtD
Fluocinonide—Hyperglycaemia—Doxorubicin—breast cancer	0.000119	0.00113	CcSEcCtD
Fluocinonide—Nervous system disorder—Docetaxel—breast cancer	0.000118	0.00112	CcSEcCtD
Fluocinonide—Pruritus—Fluorouracil—breast cancer	0.000118	0.00112	CcSEcCtD
Fluocinonide—Skin disorder—Docetaxel—breast cancer	0.000117	0.00111	CcSEcCtD
Fluocinonide—Infection—Capecitabine—breast cancer	0.000116	0.0011	CcSEcCtD
Fluocinonide—Dexamethasone—NOS2—breast cancer	0.000116	0.0321	CrCbGaD
Fluocinonide—Dizziness—Irinotecan—breast cancer	0.000115	0.00109	CcSEcCtD
Fluocinonide—Nervous system disorder—Capecitabine—breast cancer	0.000114	0.00109	CcSEcCtD
Fluocinonide—Skin disorder—Capecitabine—breast cancer	0.000113	0.00108	CcSEcCtD
Fluocinonide—Immune system disorder—Methotrexate—breast cancer	0.00011	0.00105	CcSEcCtD
Fluocinonide—Dizziness—Fluorouracil—breast cancer	0.00011	0.00105	CcSEcCtD
Fluocinonide—Rash—Irinotecan—breast cancer	0.00011	0.00104	CcSEcCtD
Fluocinonide—Rash—Mitoxantrone—breast cancer	0.00011	0.00104	CcSEcCtD
Fluocinonide—Dermatitis—Mitoxantrone—breast cancer	0.00011	0.00104	CcSEcCtD
Fluocinonide—Dermatitis—Irinotecan—breast cancer	0.00011	0.00104	CcSEcCtD
Fluocinonide—Headache—Mitoxantrone—breast cancer	0.000109	0.00104	CcSEcCtD
Fluocinonide—Headache—Irinotecan—breast cancer	0.000109	0.00104	CcSEcCtD
Fluocinonide—Budesonide—CYP3A4—breast cancer	0.000108	0.03	CrCbGaD
Fluocinonide—Rash—Gemcitabine—breast cancer	0.000107	0.00102	CcSEcCtD
Fluocinonide—Dermatitis—Gemcitabine—breast cancer	0.000107	0.00102	CcSEcCtD
Fluocinonide—Erythema—Methotrexate—breast cancer	0.000106	0.00101	CcSEcCtD
Fluocinonide—Headache—Gemcitabine—breast cancer	0.000106	0.00101	CcSEcCtD
Fluocinonide—Fluticasone furoate—CYP3A4—breast cancer	0.000106	0.0294	CrCbGaD
Fluocinonide—Dexamethasone—PGR—breast cancer	0.000105	0.0292	CrCbGaD
Fluocinonide—Rash—Fluorouracil—breast cancer	0.000105	0.001	CcSEcCtD
Fluocinonide—Dermatitis—Fluorouracil—breast cancer	0.000105	0.000999	CcSEcCtD
Fluocinonide—Hypersensitivity—Paclitaxel—breast cancer	0.000105	0.000995	CcSEcCtD
Fluocinonide—Headache—Fluorouracil—breast cancer	0.000105	0.000993	CcSEcCtD
Fluocinonide—Immune system disorder—Epirubicin—breast cancer	0.000103	0.000981	CcSEcCtD
Fluocinonide—Pain—Docetaxel—breast cancer	0.000103	0.000979	CcSEcCtD
Fluocinonide—Ciclesonide—CYP2D6—breast cancer	0.000103	0.0285	CrCbGaD
Fluocinonide—Pruritus—Paclitaxel—breast cancer	0.000101	0.000955	CcSEcCtD
Fluocinonide—Pain—Capecitabine—breast cancer	9.98e-05	0.000947	CcSEcCtD
Fluocinonide—Erythema—Epirubicin—breast cancer	9.96e-05	0.000946	CcSEcCtD
Fluocinonide—Dexamethasone—CYP1B1—breast cancer	9.84e-05	0.0273	CrCbGaD
Fluocinonide—Immune system disorder—Doxorubicin—breast cancer	9.56e-05	0.000908	CcSEcCtD
Fluocinonide—Dizziness—Paclitaxel—breast cancer	9.4e-05	0.000893	CcSEcCtD
Fluocinonide—Erythema—Doxorubicin—breast cancer	9.22e-05	0.000875	CcSEcCtD
Fluocinonide—Flunisolide—CYP3A4—breast cancer	9.06e-05	0.0251	CrCbGaD
Fluocinonide—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—breast cancer	9e-05	0.000854	CcSEcCtD
Fluocinonide—Rash—Paclitaxel—breast cancer	8.97e-05	0.000851	CcSEcCtD
Fluocinonide—Dermatitis—Paclitaxel—breast cancer	8.96e-05	0.000851	CcSEcCtD
Fluocinonide—Paramethasone—CYP3A4—breast cancer	8.95e-05	0.0248	CrCbGaD
Fluocinonide—Headache—Paclitaxel—breast cancer	8.91e-05	0.000846	CcSEcCtD
Fluocinonide—Hypersensitivity—Docetaxel—breast cancer	8.88e-05	0.000843	CcSEcCtD
Fluocinonide—Fluticasone furoate—ABCB1—breast cancer	8.82e-05	0.0245	CrCbGaD
Fluocinonide—Ciclesonide—CYP3A4—breast cancer	8.81e-05	0.0244	CrCbGaD
Fluocinonide—Fluorometholone—CYP3A4—breast cancer	8.74e-05	0.0242	CrCbGaD
Fluocinonide—Infection—Methotrexate—breast cancer	8.63e-05	0.000819	CcSEcCtD
Fluocinonide—Hypersensitivity—Capecitabine—breast cancer	8.6e-05	0.000816	CcSEcCtD
Fluocinonide—Pruritus—Docetaxel—breast cancer	8.53e-05	0.00081	CcSEcCtD
Fluocinonide—Nervous system disorder—Methotrexate—breast cancer	8.52e-05	0.000809	CcSEcCtD
Fluocinonide—Methylprednisolone—CYP3A4—breast cancer	8.45e-05	0.0234	CrCbGaD
Fluocinonide—Skin disorder—Methotrexate—breast cancer	8.44e-05	0.000801	CcSEcCtD
Fluocinonide—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—breast cancer	8.42e-05	0.0008	CcSEcCtD
Fluocinonide—Pruritus—Capecitabine—breast cancer	8.26e-05	0.000784	CcSEcCtD
Fluocinonide—Infection—Epirubicin—breast cancer	8.08e-05	0.000767	CcSEcCtD
Fluocinonide—Nervous system disorder—Epirubicin—breast cancer	7.97e-05	0.000757	CcSEcCtD
Fluocinonide—Dizziness—Docetaxel—breast cancer	7.97e-05	0.000757	CcSEcCtD
Fluocinonide—Skin disorder—Epirubicin—breast cancer	7.9e-05	0.00075	CcSEcCtD
Fluocinonide—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—breast cancer	7.79e-05	0.00074	CcSEcCtD
Fluocinonide—Dizziness—Capecitabine—breast cancer	7.72e-05	0.000733	CcSEcCtD
Fluocinonide—Rash—Docetaxel—breast cancer	7.6e-05	0.000722	CcSEcCtD
Fluocinonide—Dermatitis—Docetaxel—breast cancer	7.59e-05	0.000721	CcSEcCtD
Fluocinonide—Headache—Docetaxel—breast cancer	7.55e-05	0.000717	CcSEcCtD
Fluocinonide—Infection—Doxorubicin—breast cancer	7.47e-05	0.00071	CcSEcCtD
Fluocinonide—Pain—Methotrexate—breast cancer	7.43e-05	0.000705	CcSEcCtD
Fluocinonide—Nervous system disorder—Doxorubicin—breast cancer	7.38e-05	0.0007	CcSEcCtD
Fluocinonide—Rash—Capecitabine—breast cancer	7.36e-05	0.000699	CcSEcCtD
Fluocinonide—Dermatitis—Capecitabine—breast cancer	7.35e-05	0.000698	CcSEcCtD
Fluocinonide—Headache—Capecitabine—breast cancer	7.31e-05	0.000694	CcSEcCtD
Fluocinonide—Skin disorder—Doxorubicin—breast cancer	7.31e-05	0.000694	CcSEcCtD
Fluocinonide—Dexamethasone—CYP19A1—breast cancer	7.22e-05	0.02	CrCbGaD
Fluocinonide—Triamcinolone—CYP3A4—breast cancer	7.12e-05	0.0197	CrCbGaD
Fluocinonide—Methylprednisolone—ABCB1—breast cancer	7.03e-05	0.0195	CrCbGaD
Fluocinonide—Triamcinolone—PTGS2—breast cancer	6.97e-05	0.0193	CrCbGaD
Fluocinonide—Pain—Epirubicin—breast cancer	6.95e-05	0.00066	CcSEcCtD
Fluocinonide—Dexamethasone—ABCG2—breast cancer	6.79e-05	0.0188	CrCbGaD
Fluocinonide—Pain—Doxorubicin—breast cancer	6.43e-05	0.000611	CcSEcCtD
Fluocinonide—Hypersensitivity—Methotrexate—breast cancer	6.4e-05	0.000608	CcSEcCtD
Fluocinonide—SMO—Signaling Pathways—DLL1—breast cancer	6.38e-05	0.000662	CbGpPWpGaD
Fluocinonide—Fluticasone Propionate—CYP3A4—breast cancer	6.37e-05	0.0177	CrCbGaD
Fluocinonide—NR3C1—AP-1 transcription factor network—IL2—breast cancer	6.35e-05	0.000659	CbGpPWpGaD
Fluocinonide—NR3C1—Gene Expression—HNRNPK—breast cancer	6.35e-05	0.000659	CbGpPWpGaD
Fluocinonide—NR3C1—Gene Expression—HNRNPR—breast cancer	6.35e-05	0.000659	CbGpPWpGaD
Fluocinonide—NR3C1—Glucocorticoid receptor regulatory network—IFNG—breast cancer	6.3e-05	0.000654	CbGpPWpGaD
Fluocinonide—NR3C1—Endoderm Differentiation—CTNNB1—breast cancer	6.27e-05	0.000651	CbGpPWpGaD
Fluocinonide—NR3C1—Glucocorticoid receptor regulatory network—MDM2—breast cancer	6.26e-05	0.00065	CbGpPWpGaD
Fluocinonide—SMO—Signaling Pathways—HIST1H2BC—breast cancer	6.26e-05	0.00065	CbGpPWpGaD
Fluocinonide—SMO—Signaling Pathways—HIST1H2BK—breast cancer	6.26e-05	0.00065	CbGpPWpGaD
Fluocinonide—NR3C1—Adipogenesis—HIF1A—breast cancer	6.24e-05	0.000648	CbGpPWpGaD
Fluocinonide—NR3C1—Glucocorticoid receptor regulatory network—RELA—breast cancer	6.21e-05	0.000645	CbGpPWpGaD
Fluocinonide—SMO—Signaling Pathways—PDE4D—breast cancer	6.21e-05	0.000644	CbGpPWpGaD
Fluocinonide—SMO—Signaling Pathways—GRB7—breast cancer	6.21e-05	0.000644	CbGpPWpGaD
Fluocinonide—NR3C1—AP-1 transcription factor network—CCND1—breast cancer	6.19e-05	0.000643	CbGpPWpGaD
Fluocinonide—NR3C1—AP-1 transcription factor network—JUN—breast cancer	6.18e-05	0.000641	CbGpPWpGaD
Fluocinonide—Pruritus—Methotrexate—breast cancer	6.15e-05	0.000584	CcSEcCtD
Fluocinonide—NR3C1—AP-1 transcription factor network—CTNNB1—breast cancer	6.13e-05	0.000636	CbGpPWpGaD
Fluocinonide—SMO—Integrated Pancreatic Cancer Pathway—AKT1—breast cancer	6.11e-05	0.000634	CbGpPWpGaD
Fluocinonide—SMO—Signaling Pathways—TAB2—breast cancer	6.1e-05	0.000633	CbGpPWpGaD
Fluocinonide—NR3C1—Adipogenesis—LEP—breast cancer	6.09e-05	0.000633	CbGpPWpGaD
Fluocinonide—SMO—Signaling by GPCR—ITPR1—breast cancer	6.07e-05	0.000631	CbGpPWpGaD
Fluocinonide—SMO—Signaling Pathways—CNR2—breast cancer	6.05e-05	0.000628	CbGpPWpGaD
Fluocinonide—SMO—GPCR ligand binding—CXCL8—breast cancer	6.04e-05	0.000627	CbGpPWpGaD
Fluocinonide—SMO—Signaling by GPCR—MMP3—breast cancer	6.03e-05	0.000626	CbGpPWpGaD
Fluocinonide—NR3C1—AP-1 transcription factor network—MMP9—breast cancer	6.01e-05	0.000624	CbGpPWpGaD
Fluocinonide—Hypersensitivity—Epirubicin—breast cancer	5.99e-05	0.000569	CcSEcCtD
Fluocinonide—NR3C1—AP-1 transcription factor network—PTEN—breast cancer	5.98e-05	0.00062	CbGpPWpGaD
Fluocinonide—SMO—Signaling Pathways—DKK1—breast cancer	5.9e-05	0.000613	CbGpPWpGaD
Fluocinonide—SMO—Signaling Pathways—VEGFC—breast cancer	5.86e-05	0.000608	CbGpPWpGaD
Fluocinonide—NR3C1—Glucocorticoid receptor regulatory network—CXCL8—breast cancer	5.86e-05	0.000608	CbGpPWpGaD
Fluocinonide—Betamethasone—CYP3A4—breast cancer	5.83e-05	0.0162	CrCbGaD
Fluocinonide—NR3C1—Gene Expression—EEF1B2—breast cancer	5.81e-05	0.000603	CbGpPWpGaD
Fluocinonide—NR3C1—Gene Expression—NR2F1—breast cancer	5.81e-05	0.000603	CbGpPWpGaD
Fluocinonide—SMO—Signaling Pathways—JAG2—breast cancer	5.77e-05	0.000599	CbGpPWpGaD
Fluocinonide—Pruritus—Epirubicin—breast cancer	5.75e-05	0.000546	CcSEcCtD
Fluocinonide—Dizziness—Methotrexate—breast cancer	5.74e-05	0.000545	CcSEcCtD
Fluocinonide—Betamethasone—PTGS2—breast cancer	5.71e-05	0.0158	CrCbGaD
Fluocinonide—SMO—Signaling Pathways—WNT1—breast cancer	5.69e-05	0.00059	CbGpPWpGaD
Fluocinonide—SMO—Signaling by GPCR—PLA2G4A—breast cancer	5.67e-05	0.000589	CbGpPWpGaD
Fluocinonide—SMO—Signaling by GPCR—CSF2—breast cancer	5.61e-05	0.000582	CbGpPWpGaD
Fluocinonide—NR3C1—Glucocorticoid receptor regulatory network—IL2—breast cancer	5.6e-05	0.000581	CbGpPWpGaD
Fluocinonide—Hypersensitivity—Doxorubicin—breast cancer	5.54e-05	0.000526	CcSEcCtD
Fluocinonide—NR3C1—Regulation of nuclear SMAD2/3 signaling—JUN—breast cancer	5.5e-05	0.000571	CbGpPWpGaD
Fluocinonide—Rash—Methotrexate—breast cancer	5.48e-05	0.00052	CcSEcCtD
Fluocinonide—Dermatitis—Methotrexate—breast cancer	5.47e-05	0.00052	CcSEcCtD
Fluocinonide—NR3C1—Glucocorticoid receptor regulatory network—JUN—breast cancer	5.44e-05	0.000565	CbGpPWpGaD
Fluocinonide—Headache—Methotrexate—breast cancer	5.44e-05	0.000517	CcSEcCtD
Fluocinonide—NR3C1—Gene Expression—HNF4G—breast cancer	5.4e-05	0.00056	CbGpPWpGaD
Fluocinonide—NR3C1—Gene Expression—NR2F6—breast cancer	5.4e-05	0.00056	CbGpPWpGaD
Fluocinonide—NR3C1—SIDS Susceptibility Pathways—HIF1A—breast cancer	5.4e-05	0.00056	CbGpPWpGaD
Fluocinonide—SMO—Signaling Pathways—NOTCH4—breast cancer	5.39e-05	0.00056	CbGpPWpGaD
Fluocinonide—Dizziness—Epirubicin—breast cancer	5.38e-05	0.00051	CcSEcCtD
Fluocinonide—SMO—Signaling Pathways—GZMB—breast cancer	5.36e-05	0.000556	CbGpPWpGaD
Fluocinonide—NR3C1—Regulation of nuclear SMAD2/3 signaling—CDKN1A—breast cancer	5.33e-05	0.000553	CbGpPWpGaD
Fluocinonide—Pruritus—Doxorubicin—breast cancer	5.32e-05	0.000505	CcSEcCtD
Fluocinonide—Dexamethasone—CYP1A1—breast cancer	5.32e-05	0.0147	CrCbGaD
Fluocinonide—NR3C1—Glucocorticoid receptor regulatory network—CDKN1A—breast cancer	5.28e-05	0.000548	CbGpPWpGaD
Fluocinonide—SMO—Signaling Pathways—CXCL2—breast cancer	5.2e-05	0.00054	CbGpPWpGaD
Fluocinonide—SMO—Signaling Pathways—AGTR2—breast cancer	5.2e-05	0.00054	CbGpPWpGaD
Fluocinonide—NR3C1—Glucocorticoid receptor regulatory network—MAPK8—breast cancer	5.15e-05	0.000535	CbGpPWpGaD
Fluocinonide—SMO—Signaling Pathways—PTHLH—breast cancer	5.14e-05	0.000534	CbGpPWpGaD
Fluocinonide—SMO—Signaling Pathways—BMP2—breast cancer	5.14e-05	0.000534	CbGpPWpGaD
Fluocinonide—Rash—Epirubicin—breast cancer	5.13e-05	0.000487	CcSEcCtD
Fluocinonide—Dermatitis—Epirubicin—breast cancer	5.12e-05	0.000486	CcSEcCtD
Fluocinonide—Headache—Epirubicin—breast cancer	5.09e-05	0.000484	CcSEcCtD
Fluocinonide—NR3C1—Adipogenesis—RB1—breast cancer	5.08e-05	0.000527	CbGpPWpGaD
Fluocinonide—NR3C1—Endoderm Differentiation—TGFB1—breast cancer	5.07e-05	0.000526	CbGpPWpGaD
Fluocinonide—NR3C1—Adipogenesis—IGF1—breast cancer	5.04e-05	0.000523	CbGpPWpGaD
Fluocinonide—NR3C1—Generic Transcription Pathway—RARB—breast cancer	5.01e-05	0.00052	CbGpPWpGaD
Fluocinonide—NR3C1—FOXA2 and FOXA3 transcription factor networks—AKT1—breast cancer	4.99e-05	0.000518	CbGpPWpGaD
Fluocinonide—SMO—Signaling Pathways—EDNRB—breast cancer	4.98e-05	0.000517	CbGpPWpGaD
Fluocinonide—Dizziness—Doxorubicin—breast cancer	4.97e-05	0.000472	CcSEcCtD
Fluocinonide—NR3C1—AP-1 transcription factor network—MYC—breast cancer	4.97e-05	0.000516	CbGpPWpGaD
Fluocinonide—NR3C1—AP-1 transcription factor network—TGFB1—breast cancer	4.95e-05	0.000514	CbGpPWpGaD
Fluocinonide—SMO—Signaling Pathways—PGR—breast cancer	4.93e-05	0.000512	CbGpPWpGaD
Fluocinonide—SMO—Signaling Pathways—THBS1—breast cancer	4.91e-05	0.000509	CbGpPWpGaD
Fluocinonide—Betamethasone—ABCB1—breast cancer	4.86e-05	0.0135	CrCbGaD
Fluocinonide—NR3C1—Gene Expression—HNRNPL—breast cancer	4.81e-05	0.0005	CbGpPWpGaD
Fluocinonide—NR3C1—Generic Transcription Pathway—MED12—breast cancer	4.8e-05	0.000498	CbGpPWpGaD
Fluocinonide—NR3C1—Adipogenesis—SERPINE1—breast cancer	4.78e-05	0.000496	CbGpPWpGaD
Fluocinonide—Rash—Doxorubicin—breast cancer	4.74e-05	0.00045	CcSEcCtD
Fluocinonide—Dermatitis—Doxorubicin—breast cancer	4.74e-05	0.00045	CcSEcCtD
Fluocinonide—Headache—Doxorubicin—breast cancer	4.71e-05	0.000447	CcSEcCtD
Fluocinonide—SMO—Signaling Pathways—FLT1—breast cancer	4.68e-05	0.000486	CbGpPWpGaD
Fluocinonide—SMO—Signaling Pathways—FGF3—breast cancer	4.66e-05	0.000484	CbGpPWpGaD
Fluocinonide—SMO—Signaling Pathways—SQSTM1—breast cancer	4.66e-05	0.000484	CbGpPWpGaD
Fluocinonide—SMO—Signaling Pathways—JAG1—breast cancer	4.6e-05	0.000478	CbGpPWpGaD
Fluocinonide—SMO—Signaling Pathways—NOTCH3—breast cancer	4.58e-05	0.000476	CbGpPWpGaD
Fluocinonide—SMO—Signaling Pathways—PARP1—breast cancer	4.58e-05	0.000476	CbGpPWpGaD
Fluocinonide—SMO—Signaling Pathways—CALCA—breast cancer	4.53e-05	0.00047	CbGpPWpGaD
Fluocinonide—NR3C1—Glucocorticoid receptor regulatory network—MAPK3—breast cancer	4.5e-05	0.000467	CbGpPWpGaD
Fluocinonide—SMO—Signaling Pathways—RPS6—breast cancer	4.47e-05	0.000464	CbGpPWpGaD
Fluocinonide—SMO—Signaling Pathways—FGF4—breast cancer	4.44e-05	0.000461	CbGpPWpGaD
Fluocinonide—SMO—Signaling Pathways—CXCR4—breast cancer	4.42e-05	0.000459	CbGpPWpGaD
Fluocinonide—SMO—Signaling Pathways—CXCL12—breast cancer	4.42e-05	0.000459	CbGpPWpGaD
Fluocinonide—NR3C1—Regulation of nuclear SMAD2/3 signaling—MYC—breast cancer	4.42e-05	0.000459	CbGpPWpGaD
Fluocinonide—NR3C1—Generic Transcription Pathway—NOTCH4—breast cancer	4.35e-05	0.000452	CbGpPWpGaD
Fluocinonide—SMO—Signaling Pathways—PAK1—breast cancer	4.34e-05	0.000451	CbGpPWpGaD
Fluocinonide—SMO—Signaling Pathways—TCF7L2—breast cancer	4.26e-05	0.000443	CbGpPWpGaD
Fluocinonide—SMO—Signaling by GPCR—PIK3CG—breast cancer	4.21e-05	0.000437	CbGpPWpGaD
Fluocinonide—SMO—Signaling Pathways—NOTCH2—breast cancer	4.11e-05	0.000427	CbGpPWpGaD
Fluocinonide—SMO—Signaling Pathways—HSP90AA1—breast cancer	4.11e-05	0.000427	CbGpPWpGaD
Fluocinonide—NR3C1—AP-1 transcription factor network—TP53—breast cancer	4.08e-05	0.000423	CbGpPWpGaD
Fluocinonide—SMO—Signaling Pathways—PRL—breast cancer	4e-05	0.000415	CbGpPWpGaD
Fluocinonide—SMO—Signaling Pathways—AGTR1—breast cancer	4e-05	0.000415	CbGpPWpGaD
Fluocinonide—NR3C1—Generic Transcription Pathway—PGR—breast cancer	3.98e-05	0.000413	CbGpPWpGaD
Fluocinonide—NR3C1—Gene Expression—EIF2S2—breast cancer	3.96e-05	0.000411	CbGpPWpGaD
Fluocinonide—Dexamethasone—CYP2D6—breast cancer	3.96e-05	0.011	CrCbGaD
Fluocinonide—SMO—Signaling Pathways—ADAM10—breast cancer	3.94e-05	0.000409	CbGpPWpGaD
Fluocinonide—SMO—Signaling Pathways—STK11—breast cancer	3.94e-05	0.000409	CbGpPWpGaD
Fluocinonide—SMO—Signaling Pathways—PLG—breast cancer	3.9e-05	0.000405	CbGpPWpGaD
Fluocinonide—SMO—Signaling by GPCR—AKT2—breast cancer	3.85e-05	0.0004	CbGpPWpGaD
Fluocinonide—NR3C1—Gene Expression—ESRRA—breast cancer	3.85e-05	0.000399	CbGpPWpGaD
Fluocinonide—SMO—Signaling Pathways—FGF10—breast cancer	3.83e-05	0.000398	CbGpPWpGaD
Fluocinonide—NR3C1—Generic Transcription Pathway—NCOA2—breast cancer	3.83e-05	0.000398	CbGpPWpGaD
Fluocinonide—NR3C1—Adipogenesis—CTNNB1—breast cancer	3.74e-05	0.000388	CbGpPWpGaD
Fluocinonide—NR3C1—AP-1 transcription factor network—IL6—breast cancer	3.73e-05	0.000388	CbGpPWpGaD
Fluocinonide—SMO—Signaling by GPCR—PIK3CD—breast cancer	3.7e-05	0.000384	CbGpPWpGaD
Fluocinonide—SMO—Signaling Pathways—PDGFA—breast cancer	3.7e-05	0.000384	CbGpPWpGaD
Fluocinonide—NR3C1—Generic Transcription Pathway—PARP1—breast cancer	3.7e-05	0.000384	CbGpPWpGaD
Fluocinonide—NR3C1—Generic Transcription Pathway—NOTCH3—breast cancer	3.7e-05	0.000384	CbGpPWpGaD
Fluocinonide—NR3C1—Adipogenesis—CDKN1A—breast cancer	3.65e-05	0.000379	CbGpPWpGaD
Fluocinonide—NR3C1—Gene Expression—YBX1—breast cancer	3.65e-05	0.000379	CbGpPWpGaD
Fluocinonide—SMO—Signaling Pathways—TGFBR2—breast cancer	3.65e-05	0.000379	CbGpPWpGaD
Fluocinonide—NR3C1—Glucocorticoid receptor regulatory network—TP53—breast cancer	3.59e-05	0.000373	CbGpPWpGaD
Fluocinonide—SMO—Signaling Pathways—ITPR1—breast cancer	3.59e-05	0.000373	CbGpPWpGaD
Fluocinonide—SMO—Signaling Pathways—STAT5A—breast cancer	3.56e-05	0.00037	CbGpPWpGaD
Fluocinonide—SMO—Signaling Pathways—MMP3—breast cancer	3.56e-05	0.00037	CbGpPWpGaD
Fluocinonide—SMO—Signaling Pathways—ERBB4—breast cancer	3.56e-05	0.00037	CbGpPWpGaD
Fluocinonide—NR3C1—Generic Transcription Pathway—ESR2—breast cancer	3.5e-05	0.000364	CbGpPWpGaD
Fluocinonide—NR3C1—SIDS Susceptibility Pathways—CXCL8—breast cancer	3.5e-05	0.000363	CbGpPWpGaD
Fluocinonide—NR3C1—Gene Expression—THRB—breast cancer	3.48e-05	0.000361	CbGpPWpGaD
Fluocinonide—NR3C1—Gene Expression—EEF2—breast cancer	3.48e-05	0.000361	CbGpPWpGaD
Fluocinonide—SMO—Signaling Pathways—SMAD4—breast cancer	3.45e-05	0.000358	CbGpPWpGaD
Fluocinonide—SMO—Signaling Pathways—IGF1R—breast cancer	3.43e-05	0.000356	CbGpPWpGaD
Fluocinonide—Dexamethasone—CYP3A4—breast cancer	3.39e-05	0.00941	CrCbGaD
Fluocinonide—SMO—Signaling Pathways—HES1—breast cancer	3.37e-05	0.00035	CbGpPWpGaD
Fluocinonide—NR3C1—SIDS Susceptibility Pathways—IL1B—breast cancer	3.36e-05	0.000349	CbGpPWpGaD
Fluocinonide—SMO—Signaling Pathways—PLA2G4A—breast cancer	3.35e-05	0.000348	CbGpPWpGaD
Fluocinonide—SMO—Signaling Pathways—NCOR1—breast cancer	3.35e-05	0.000348	CbGpPWpGaD
Fluocinonide—NR3C1—SIDS Susceptibility Pathways—CASP3—breast cancer	3.35e-05	0.000348	CbGpPWpGaD
Fluocinonide—NR3C1—Gene Expression—TET2—breast cancer	3.34e-05	0.000346	CbGpPWpGaD
Fluocinonide—NR3C1—Gene Expression—RXRB—breast cancer	3.34e-05	0.000346	CbGpPWpGaD
Fluocinonide—Dexamethasone—PTGS2—breast cancer	3.32e-05	0.00921	CrCbGaD
Fluocinonide—NR3C1—Generic Transcription Pathway—NOTCH2—breast cancer	3.32e-05	0.000344	CbGpPWpGaD
Fluocinonide—SMO—Signaling Pathways—FGF1—breast cancer	3.31e-05	0.000344	CbGpPWpGaD
Fluocinonide—SMO—Signaling Pathways—CSF2—breast cancer	3.31e-05	0.000344	CbGpPWpGaD
Fluocinonide—SMO—Signaling by GPCR—RAF1—breast cancer	3.31e-05	0.000343	CbGpPWpGaD
Fluocinonide—SMO—Signaling Pathways—NRG1—breast cancer	3.29e-05	0.000341	CbGpPWpGaD
Fluocinonide—NR3C1—Glucocorticoid receptor regulatory network—IL6—breast cancer	3.29e-05	0.000341	CbGpPWpGaD
Fluocinonide—NR3C1—Gene Expression—RPL31—breast cancer	3.27e-05	0.00034	CbGpPWpGaD
Fluocinonide—SMO—Signaling Pathways—H2AFX—breast cancer	3.27e-05	0.000339	CbGpPWpGaD
Fluocinonide—NR3C1—Adipogenesis—STAT3—breast cancer	3.26e-05	0.000338	CbGpPWpGaD
Fluocinonide—NR3C1—SIDS Susceptibility Pathways—JUN—breast cancer	3.25e-05	0.000338	CbGpPWpGaD
Fluocinonide—SMO—Signaling Pathways—E2F1—breast cancer	3.24e-05	0.000337	CbGpPWpGaD
Fluocinonide—NR3C1—SIDS Susceptibility Pathways—CTNNB1—breast cancer	3.23e-05	0.000335	CbGpPWpGaD
Fluocinonide—SMO—Signaling by GPCR—PIK3CB—breast cancer	3.23e-05	0.000335	CbGpPWpGaD
Fluocinonide—NR3C1—Generic Transcription Pathway—NCOA1—breast cancer	3.23e-05	0.000335	CbGpPWpGaD
Fluocinonide—SMO—Signaling Pathways—SPP1—breast cancer	3.12e-05	0.000323	CbGpPWpGaD
Fluocinonide—SMO—Signaling by GPCR—CXCL8—breast cancer	3.1e-05	0.000322	CbGpPWpGaD
Fluocinonide—NR3C1—Generic Transcription Pathway—AR—breast cancer	3.09e-05	0.000321	CbGpPWpGaD
Fluocinonide—SMO—Signaling Pathways—ERBB3—breast cancer	3.08e-05	0.00032	CbGpPWpGaD
Fluocinonide—SMO—Signaling Pathways—FGFR2—breast cancer	3.08e-05	0.000319	CbGpPWpGaD
Fluocinonide—NR3C1—Regulation of nuclear SMAD2/3 signaling—AKT1—breast cancer	3.06e-05	0.000318	CbGpPWpGaD
Fluocinonide—NR3C1—Gene Expression—RPS4X—breast cancer	3.05e-05	0.000317	CbGpPWpGaD
Fluocinonide—NR3C1—Glucocorticoid receptor regulatory network—AKT1—breast cancer	3.03e-05	0.000315	CbGpPWpGaD
Fluocinonide—NR3C1—Adipogenesis—TGFB1—breast cancer	3.02e-05	0.000313	CbGpPWpGaD
Fluocinonide—NR3C1—Gene Expression—EIF3A—breast cancer	3e-05	0.000312	CbGpPWpGaD
Fluocinonide—SMO—Signaling by GPCR—IL2—breast cancer	2.96e-05	0.000308	CbGpPWpGaD
Fluocinonide—NR3C1—Gene Expression—DNMT3A—breast cancer	2.96e-05	0.000307	CbGpPWpGaD
Fluocinonide—SMO—Signaling Pathways—TERT—breast cancer	2.95e-05	0.000307	CbGpPWpGaD
Fluocinonide—NR3C1—Gene Expression—ELL—breast cancer	2.92e-05	0.000303	CbGpPWpGaD
Fluocinonide—SMO—Signaling Pathways—FGFR1—breast cancer	2.87e-05	0.000298	CbGpPWpGaD
Fluocinonide—NR3C1—SIDS Susceptibility Pathways—VEGFA—breast cancer	2.84e-05	0.000295	CbGpPWpGaD
Fluocinonide—Dexamethasone—ABCB1—breast cancer	2.82e-05	0.00783	CrCbGaD
Fluocinonide—SMO—Signaling Pathways—HIF1A—breast cancer	2.82e-05	0.000293	CbGpPWpGaD
Fluocinonide—NR3C1—Adipogenesis—TNF—breast cancer	2.82e-05	0.000293	CbGpPWpGaD
Fluocinonide—NR3C1—Generic Transcription Pathway—SMAD4—breast cancer	2.79e-05	0.000289	CbGpPWpGaD
Fluocinonide—NR3C1—Generic Transcription Pathway—VDR—breast cancer	2.78e-05	0.000289	CbGpPWpGaD
Fluocinonide—SMO—Signaling Pathways—LEP—breast cancer	2.76e-05	0.000286	CbGpPWpGaD
Fluocinonide—SMO—Signaling Pathways—CAV1—breast cancer	2.73e-05	0.000284	CbGpPWpGaD
Fluocinonide—NR3C1—Generic Transcription Pathway—NCOR1—breast cancer	2.7e-05	0.000281	CbGpPWpGaD
Fluocinonide—SMO—Signaling Pathways—KDR—breast cancer	2.7e-05	0.00028	CbGpPWpGaD
Fluocinonide—NR3C1—Gene Expression—PABPC1—breast cancer	2.7e-05	0.00028	CbGpPWpGaD
Fluocinonide—SMO—Signaling Pathways—ESR1—breast cancer	2.63e-05	0.000273	CbGpPWpGaD
Fluocinonide—SMO—Signaling Pathways—FN1—breast cancer	2.6e-05	0.00027	CbGpPWpGaD
Fluocinonide—SMO—Signaling Pathways—NFKBIA—breast cancer	2.57e-05	0.000267	CbGpPWpGaD
Fluocinonide—SMO—Signaling Pathways—NOTCH1—breast cancer	2.54e-05	0.000264	CbGpPWpGaD
Fluocinonide—NR3C1—Gene Expression—DNMT3B—breast cancer	2.53e-05	0.000262	CbGpPWpGaD
Fluocinonide—SMO—Signaling Pathways—KIT—breast cancer	2.49e-05	0.000258	CbGpPWpGaD
Fluocinonide—SMO—Signaling Pathways—APC—breast cancer	2.49e-05	0.000258	CbGpPWpGaD
Fluocinonide—SMO—Signaling Pathways—PIK3CG—breast cancer	2.49e-05	0.000258	CbGpPWpGaD
Fluocinonide—NR3C1—Gene Expression—RPL23A—breast cancer	2.48e-05	0.000257	CbGpPWpGaD
Fluocinonide—SMO—Signaling Pathways—EGF—breast cancer	2.46e-05	0.000255	CbGpPWpGaD
Fluocinonide—NR3C1—SIDS Susceptibility Pathways—TNF—breast cancer	2.44e-05	0.000253	CbGpPWpGaD
Fluocinonide—NR3C1—Gene Expression—HIST1H2BC—breast cancer	2.43e-05	0.000253	CbGpPWpGaD
Fluocinonide—NR3C1—Gene Expression—HIST1H2BK—breast cancer	2.43e-05	0.000253	CbGpPWpGaD
Fluocinonide—NR3C1—Gene Expression—RARB—breast cancer	2.41e-05	0.00025	CbGpPWpGaD
Fluocinonide—SMO—Signaling by GPCR—MAPK3—breast cancer	2.38e-05	0.000247	CbGpPWpGaD
Fluocinonide—SMO—Signaling Pathways—BRAF—breast cancer	2.34e-05	0.000243	CbGpPWpGaD
Fluocinonide—NR3C1—Gene Expression—MED12—breast cancer	2.31e-05	0.00024	CbGpPWpGaD
Fluocinonide—NR3C1—Gene Expression—RPS7—breast cancer	2.31e-05	0.00024	CbGpPWpGaD
Fluocinonide—NR3C1—Gene Expression—RPS8—breast cancer	2.31e-05	0.00024	CbGpPWpGaD
Fluocinonide—SMO—Signaling Pathways—IGF1—breast cancer	2.28e-05	0.000237	CbGpPWpGaD
Fluocinonide—SMO—Signaling Pathways—AKT2—breast cancer	2.28e-05	0.000236	CbGpPWpGaD
Fluocinonide—NR3C1—Adipogenesis—IL6—breast cancer	2.27e-05	0.000236	CbGpPWpGaD
Fluocinonide—SMO—Signaling by GPCR—EGFR—breast cancer	2.27e-05	0.000235	CbGpPWpGaD
Fluocinonide—SMO—Signaling Pathways—PIK3CD—breast cancer	2.19e-05	0.000227	CbGpPWpGaD
Fluocinonide—SMO—Signaling Pathways—SERPINE1—breast cancer	2.16e-05	0.000225	CbGpPWpGaD
Fluocinonide—SMO—Signaling by GPCR—KRAS—breast cancer	2.14e-05	0.000222	CbGpPWpGaD
Fluocinonide—NR3C1—Generic Transcription Pathway—ESR1—breast cancer	2.12e-05	0.000221	CbGpPWpGaD
Fluocinonide—NR3C1—Gene Expression—NOTCH4—breast cancer	2.09e-05	0.000217	CbGpPWpGaD
Fluocinonide—SMO—Signaling Pathways—NOS3—breast cancer	2.07e-05	0.000214	CbGpPWpGaD
Fluocinonide—NR3C1—Generic Transcription Pathway—NOTCH1—breast cancer	2.05e-05	0.000213	CbGpPWpGaD
Fluocinonide—NR3C1—Gene Expression—HSPA1B—breast cancer	2e-05	0.000207	CbGpPWpGaD
Fluocinonide—SMO—Signaling by GPCR—PIK3CA—breast cancer	1.97e-05	0.000204	CbGpPWpGaD
Fluocinonide—NR3C1—SIDS Susceptibility Pathways—IL6—breast cancer	1.97e-05	0.000204	CbGpPWpGaD
Fluocinonide—SMO—Signaling Pathways—MDM2—breast cancer	1.96e-05	0.000203	CbGpPWpGaD
Fluocinonide—SMO—Signaling Pathways—RAF1—breast cancer	1.95e-05	0.000203	CbGpPWpGaD
Fluocinonide—SMO—Signaling Pathways—RELA—breast cancer	1.94e-05	0.000202	CbGpPWpGaD
Fluocinonide—SMO—Signaling Pathways—ERBB2—breast cancer	1.93e-05	0.000201	CbGpPWpGaD
Fluocinonide—NR3C1—Gene Expression—PGR—breast cancer	1.92e-05	0.000199	CbGpPWpGaD
Fluocinonide—SMO—Signaling Pathways—MTOR—breast cancer	1.91e-05	0.000198	CbGpPWpGaD
Fluocinonide—SMO—Signaling Pathways—PIK3CB—breast cancer	1.91e-05	0.000198	CbGpPWpGaD
Fluocinonide—NR3C1—Gene Expression—DNMT1—breast cancer	1.88e-05	0.000195	CbGpPWpGaD
Fluocinonide—NR3C1—Gene Expression—NCOA2—breast cancer	1.84e-05	0.000191	CbGpPWpGaD
Fluocinonide—SMO—Signaling Pathways—CXCL8—breast cancer	1.83e-05	0.00019	CbGpPWpGaD
Fluocinonide—SMO—Signaling by GPCR—HRAS—breast cancer	1.82e-05	0.000189	CbGpPWpGaD
Fluocinonide—NR3C1—Gene Expression—EZH2—breast cancer	1.82e-05	0.000189	CbGpPWpGaD
Fluocinonide—SMO—Signaling Pathways—CDKN1B—breast cancer	1.79e-05	0.000186	CbGpPWpGaD
Fluocinonide—NR3C1—Gene Expression—PARP1—breast cancer	1.78e-05	0.000185	CbGpPWpGaD
Fluocinonide—NR3C1—Gene Expression—NOTCH3—breast cancer	1.78e-05	0.000185	CbGpPWpGaD
Fluocinonide—SMO—Signaling Pathways—CASP3—breast cancer	1.75e-05	0.000182	CbGpPWpGaD
Fluocinonide—SMO—Signaling Pathways—IL2—breast cancer	1.75e-05	0.000182	CbGpPWpGaD
Fluocinonide—NR3C1—Generic Transcription Pathway—SERPINE1—breast cancer	1.75e-05	0.000181	CbGpPWpGaD
Fluocinonide—SMO—Signaling by GPCR—IL6—breast cancer	1.74e-05	0.000181	CbGpPWpGaD
Fluocinonide—NR3C1—Gene Expression—RPS6—breast cancer	1.74e-05	0.00018	CbGpPWpGaD
Fluocinonide—SMO—Signaling Pathways—CCND1—breast cancer	1.71e-05	0.000177	CbGpPWpGaD
Fluocinonide—SMO—Signaling Pathways—JUN—breast cancer	1.7e-05	0.000177	CbGpPWpGaD
Fluocinonide—SMO—Signaling Pathways—CTNNB1—breast cancer	1.69e-05	0.000175	CbGpPWpGaD
Fluocinonide—NR3C1—Gene Expression—ESR2—breast cancer	1.69e-05	0.000175	CbGpPWpGaD
Fluocinonide—SMO—Signaling Pathways—MMP9—breast cancer	1.66e-05	0.000172	CbGpPWpGaD
Fluocinonide—SMO—Signaling Pathways—CDKN1A—breast cancer	1.65e-05	0.000171	CbGpPWpGaD
Fluocinonide—SMO—Signaling Pathways—PTEN—breast cancer	1.65e-05	0.000171	CbGpPWpGaD
Fluocinonide—SMO—Signaling Pathways—MAPK8—breast cancer	1.61e-05	0.000167	CbGpPWpGaD
Fluocinonide—SMO—Signaling by GPCR—AKT1—breast cancer	1.61e-05	0.000167	CbGpPWpGaD
Fluocinonide—NR3C1—Gene Expression—NOTCH2—breast cancer	1.6e-05	0.000166	CbGpPWpGaD
Fluocinonide—NR3C1—Gene Expression—NCOA1—breast cancer	1.55e-05	0.000161	CbGpPWpGaD
Fluocinonide—SMO—Signaling Pathways—SRC—breast cancer	1.53e-05	0.000159	CbGpPWpGaD
Fluocinonide—NR3C1—Gene Expression—AR—breast cancer	1.49e-05	0.000155	CbGpPWpGaD
Fluocinonide—SMO—Signaling Pathways—VEGFA—breast cancer	1.49e-05	0.000154	CbGpPWpGaD
Fluocinonide—SMO—Signaling Pathways—STAT3—breast cancer	1.47e-05	0.000153	CbGpPWpGaD
Fluocinonide—SMO—Signaling Pathways—MAPK3—breast cancer	1.41e-05	0.000146	CbGpPWpGaD
Fluocinonide—SMO—Signaling Pathways—MYC—breast cancer	1.37e-05	0.000142	CbGpPWpGaD
Fluocinonide—SMO—Signaling Pathways—TGFB1—breast cancer	1.37e-05	0.000142	CbGpPWpGaD
Fluocinonide—NR3C1—Gene Expression—SIRT1—breast cancer	1.36e-05	0.000141	CbGpPWpGaD
Fluocinonide—NR3C1—Gene Expression—SMAD4—breast cancer	1.34e-05	0.000139	CbGpPWpGaD
Fluocinonide—SMO—Signaling Pathways—EGFR—breast cancer	1.34e-05	0.000139	CbGpPWpGaD
Fluocinonide—NR3C1—Gene Expression—VDR—breast cancer	1.34e-05	0.000139	CbGpPWpGaD
Fluocinonide—NR3C1—Gene Expression—NCOR1—breast cancer	1.3e-05	0.000135	CbGpPWpGaD
Fluocinonide—NR3C1—Gene Expression—H2AFX—breast cancer	1.27e-05	0.000132	CbGpPWpGaD
Fluocinonide—SMO—Signaling Pathways—KRAS—breast cancer	1.27e-05	0.000131	CbGpPWpGaD
Fluocinonide—NR3C1—Gene Expression—ERCC2—breast cancer	1.22e-05	0.000127	CbGpPWpGaD
Fluocinonide—SMO—Signaling Pathways—PIK3CA—breast cancer	1.16e-05	0.000121	CbGpPWpGaD
Fluocinonide—SMO—Signaling Pathways—TP53—breast cancer	1.12e-05	0.000117	CbGpPWpGaD
Fluocinonide—NR3C1—Generic Transcription Pathway—MYC—breast cancer	1.11e-05	0.000115	CbGpPWpGaD
Fluocinonide—SMO—Signaling Pathways—HRAS—breast cancer	1.08e-05	0.000112	CbGpPWpGaD
Fluocinonide—SMO—Signaling Pathways—IL6—breast cancer	1.03e-05	0.000107	CbGpPWpGaD
Fluocinonide—NR3C1—Gene Expression—ESR1—breast cancer	1.02e-05	0.000106	CbGpPWpGaD
Fluocinonide—NR3C1—Gene Expression—NOTCH1—breast cancer	9.89e-06	0.000103	CbGpPWpGaD
Fluocinonide—SMO—Signaling Pathways—AKT1—breast cancer	9.49e-06	9.86e-05	CbGpPWpGaD
Fluocinonide—NR3C1—Gene Expression—SERPINE1—breast cancer	8.41e-06	8.73e-05	CbGpPWpGaD
Fluocinonide—NR3C1—Gene Expression—MAPK3—breast cancer	5.47e-06	5.68e-05	CbGpPWpGaD
Fluocinonide—NR3C1—Gene Expression—MYC—breast cancer	5.32e-06	5.52e-05	CbGpPWpGaD
Fluocinonide—NR3C1—Gene Expression—AKT1—breast cancer	3.69e-06	3.83e-05	CbGpPWpGaD
